Combined treatment with acalabrutinib and rapamycin inhibits glioma stem cells and promotes vascular normalization by downregulating btk/mtor/vegf signaling

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combined treatment with acalabrutinib and rapamycin inhibits glioma stem cells and promotes vascular normalization by downregulating btk/mtor/vegf signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds